Epigenetic silencing of Arginino-Succinate Synthase (Ass1) defines Arginine Depletion Therapy as a novel treatment strategy for breast cancer

F. Cavicchioli, A. Shia, K. O'Leary, V. Haley, C. Palmieri, N. Syed, T. Crook, A. M. Thompson, C. Lo Nigro, P. Schmid

    Research output: Contribution to journalMeeting abstract

    Original languageEnglish
    Article number1660P
    Pages (from-to)532-533
    Number of pages2
    JournalAnnals of Oncology
    Volume23
    Issue numberS9
    DOIs
    Publication statusPublished - 2012
    Event37th ESMO Congress Vienna, Austria, 28 September – 2 October 2012 - Vienna, Austria
    Duration: 28 Sep 20122 Oct 2012

    Cite this

    Cavicchioli, F., Shia, A., O'Leary, K., Haley, V., Palmieri, C., Syed, N., Crook, T., Thompson, A. M., Lo Nigro, C., & Schmid, P. (2012). Epigenetic silencing of Arginino-Succinate Synthase (Ass1) defines Arginine Depletion Therapy as a novel treatment strategy for breast cancer. Annals of Oncology, 23(S9), 532-533. [1660P]. https://doi.org/10.1093/annonc/mds417